Stay Away From Prempro and Premarin, Study Says; Bio-Identical Hormones are Safe and Do Not Trigger Breast Cancer, Advises Dr. C.W. Randolph

Share Article

Bio-Identical Progesterone is safe, actually decreasing the risk of breast cancer, says author of "From Hormone Hell to Hormone Well."

Women are wondering why bio-identical hormones are safe and cancer protective, while synthetic hormones are linked to an increased risk of breast cancer after all of the recent media attention.

"All hormones are not the same," says C.W. Randolph, author of the best selling book "From Hormone Hell to Hormone Well. "Bio-identical progesterone is so safe that in some cases, doctors give it to women who are at risk of losing a baby while if they gave her progestin it would be lethal to the child, and bio-identical progesterone has also shown to protect against breast cancer."

C.W. Randolph, Jr., M.D., R.Ph., both a trained pharmacist and a practicing board certified gynecologist, is one of the nation's leading authorities on bio-identical hormone therapies

"In the study released this month, there is a reported 7.2 percent decline in breast cancer rates of women over 50," said Dr. Randolph. "This is linked to the fact that, since the Women's Health Initiative Study was published in 2002 linking synthetic hormones such as Premarin and Prempro to an increase risk of breast cancer, many women decided to go cold turkey and stop filling their prescriptions for synthetic hormone therapies."

According to Dr. Randolph, the drop in the number of women diagnosed with breast cancer is also directly linked to the large number of women who either chose to switch to bio-identical hormone therapies or simply chose bio-identical hormone replacement as their first choice in treatment.

"Over 38 million American women are now entering pre-menopause or menopause and they are seeking alternative solutions to treat the symptoms associated with PMS and menopause," says Dr. Randolph. "Thankfully the Women's Health Initiative study showing that synthetic hormones increase a woman's risk of breast cancer has made women seek alternative methods such as bio-identical hormones. The prescribed synthetic hormones such as Premarin or Prempro, remain a potential poison to women and I'm glad that finally significant changes are being made in women's receptivity to these potential time bombs."

When asked to explain how bio-identical hormones differ from synthetic hormones, Dr. Randolph stated: "Bio-identical hormones are exactly the same molecular structure as the hormone produced within the body. As a result, the body's hormone receptors recognize bio-identical hormones and accept them. Synthetic hormones have a slightly different molecular structure. Even a small difference can trigger side effects at the cellular level. An increased risk of cancer is one of those side effects."

"For example, Progestin, the molecular compound found in Prempro, is a synthetic form of progesterone whose molecular structure has been changed. It can trigger dangerous side effects in the body. Bio-identical progesterone is very different from synthetic progestin. "Bio-identical progesterone is not only safe to use, it can help decrease a woman's risk for developing cancer," says Dr. Randolph. "I currently lecture to physicians around the country sharing clinical studies and medical data that validates the fact that bio-identical progesterone has many cancer-protective benefits. The bio-chemistry of why this is so is actually quite simple: progesterone neutralizes the cancer-promoting properties associated with too much estrogen in the body. While estrogen promotes cell proliferation, or cell growth, progesterone decreases cell growth. Too much cell growth is a precursor for cancer."

"In my gynecology practice, I have prescribed bio-identical progesterone for over a decade and I have never had a patient on my bio-identical hormone regimen develop cancer. I even have patients who are breast cancer survivors who I prescribe bio-identical progesterone because my experience, and the research shows, that the progesterone can play a key role in preventing a recurrence of the original cancer."

"Obviously, more studies are needed to validate the cancer-protective properties of bio-identical progesterone."

Why aren't there more clinical studies investigating the safety and efficacy of bio-identical hormones? According to Dr. Randolph, it really boils down to two things: 1) lack of knowledge within the medical community because physicians have not been educated in medical school about the option of bio-identical hormone replacement and 2) the ability of major pharmaceutical companies to twist and manipulate the idea of hormone replacement to capitalize on a business opportunity.

"Synthetic hormones are produced in a lab and have a genetically modified structure, they can be patented." Dr. Randolph said, "This allows big drug companies to market and sell this product exclusively, thus creating profits. Big pharmaceutical companies would not market, or fund research studies investigating, bio-identical hormones. Why should they? There is no way for them to make a buck on products that can't be patented."

"The pharmaceutical industry is the top funder of specialty forums and continuing medical education meetings for doctors. They offer physicians some nice 'perks,' such as dinners, fishing trips and sporting event tickets. Credible or questionable, the dollars the pharmaceutical companies spend gets them the ear of the physician."

"Smart, informed and demanding women are finding their voice and they want data that they can believe and trust," concludes Dr. Randolph. "I believe every physician should embody their original role as patient advocate and demand that the safety and effectiveness of bio-identical hormones be a top priority for each medical university's research agenda. The pharmaceutical industry's marketing hype needs to be replaced with solid medical evidence. Bio-identical hormone replacement is a safe and effective option for women and men seeking treatment for hormone imbalances."

To schedule an interview with Dr. Randolph, contact Nanette Noffsinger at 615-776-4230.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Visit website